UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000034670 |
|---|---|
| Receipt number | R000039525 |
| Scientific Title | RH-PAT in the patients with type two diabetes (a retrospective study) |
| Date of disclosure of the study information | 2018/11/01 |
| Last modified on | 2018/10/27 23:11:05 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
RH-PAT in the patients with type two diabetes (a retrospective study)
Acronym
RH-PAT in the patients with type two diabetes
Scientific Title
RH-PAT in the patients with type two diabetes (a retrospective study)
Scientific Title:Acronym
RH-PAT in the patients with type two diabetes
Region
| Japan |
Condition
Condition
type two diabetes mellitus
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
We performe RH-PAT to the patients who are admitted to our hospital for blood glucose control. We aim to see the association between the RHI and the clinical conditions.
Basic objectives2
Others
Basic objectives -Others
none
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
RHI to see the function of vascular endothelium during the hospitalization for the control of blood glucose.
Key secondary outcomes
none
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 80 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
type two diabetes patients who are admitted to our hospital for the control of the blood glucose control
Key exclusion criteria
patiens with infectious disease, diabetic ketoacidosis, myocardial infarction
Target sample size
120
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Rikako Ukichi |
Organization
Jikei University School of Medicine
Division name
Diabetes, metabolism and endocrinology
Zip code
Address
Nishishimbashi, 3-25-8, Minato-ku, Tokyo
TEL
0334331111
risuzuki@jikei.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Rikako Ukichi |
Organization
Jikei University School of Medicine
Division name
Diabetes, metabolism and endocrinology
Zip code
Address
Nishishimbashi, 3-25-8, Minato-ku, Tokyo
TEL
0334331111
Homepage URL
risuzuki@jikei.ac.jp
Sponsor or person
Institute
Jikei University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Jikei University School of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 11 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2016 | Year | 04 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 04 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We aime to see the association between the microvascular damage, coexisting diseases of the type two diabetes and endovascular damage.
Management information
Registered date
| 2018 | Year | 10 | Month | 27 | Day |
Last modified on
| 2018 | Year | 10 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039525
